Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

I found the content of the CEO blog very positive. I'm sure that doesn't surprise you too much. The thumbs up from the DSMB regarding the EPIC trial data from first cohort of subjects was the most important piece from the blog post. Personally I wish this piece had come out as a single PR, but that's a moot point right now.

After that, the initiation of the nonclinical study in Thrombotic stroke is something that I have been waiting for and I am pleased it is underway.

Good to read that the application to the EU for ODD in ALI has been submitted. That should be approved and designated in a timely manner considering we already have approval in US.

Air001 data and plans for development should be a good catalyst for the PPS this quarter, but predicting PPS is something than I don't like to do. Too difficult IMO. I'll just say that I continue to like the Risk/Reward for this stock very much.

Have a good day everyone. RR